Novozymes inaugurates R&D laboratories in Brazil

Today, Novozymes opens a new R&D facility in Brazil that will focus initially on developing new enzyme products for the rapidly expanding bioenergy sector in Brazil.

Today, Novozymes, a world leader in bioinnovation, opens new R&D laboratories and Customer Solutions facilities that will expand existing R&D efforts at Novozymes’ site in Araucária, a city nearby Curitiba, Paraná, Brazil. 

Brazil is a global leader in biofuels, and plans to double its production of fuel ethanol by 2020.

The new Novozymes center will strengthen research in a wide range of industries, including household care, agriculture and baking applications. The initial focus will be on bioenergy.

“Our new facilities and expanded research capacity will promote the growth of advanced biofuels in Brazil, an industry that creates jobs, fosters development of new technology, provides new export opportunities for Brazil and Latin America, and creates sustainable solutions essential to the world,” says Pedro Luiz Fernandes, Regional President for Novozymes in Latin America.

Brazil: a global leader in biofuel innovation
Brazil is one of the world’s largest producers of sugarcane, biofuels, and flex-fuel cars, all of which are predicted to experience growing demand in the rest of the world in coming years. 90% of new cars made in Brazil are flex-fuel which are highly efficient and run on both gasoline and fuel ethanol. 

Brazil expects to double its output of fuel ethanol by 2020 to meet the growing demand from both domestic and export markets.  Novozymes’ studies indicate that by using sugarcane bagasse and straw, the volume of ethanol can be doubled using the same amount of land.

Novozymes is already collaborating with major players in Latin America -  Dedini, Cetrel, CTC (Centro de Technologicia Canaviera) and Petrobras, the largest company in Latin America - to pursue research and commercialization of advanced biofuels in Brazil.

A strong commitment to Novozymes’ global R&D network
The new research center represents a major expansion for Novozymes in Brazil, expanding the workforce in Brazil by approximately 10%, and significantly strengthening R&D competences of the current workforce, which traditionally has focused on production, administration, sales, customer support, and sustainability. 

Novozymes’ R&D is located in eight sites globally (two sites in USA, plus England, Denmark, India, China, Japan and Brazil) with each site representing a certain set of skills and competences, and all sites tied together by global project- and knowledge-management systems. Novozymes invests heavily in R&D – on average 14% of global sales turnover per year.

Thus the new Brazilian research center becomes part of the well-funded, global corporate network.